Inovio Pharmaceuticals
INO
#9441
Rank
โ‚ฌ55.6 M
Marketcap
1,52ย โ‚ฌ
Share price
10.67%
Change (1 day)
-86.84%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2024 (TTM): โ‚ฌ0.2 Million

According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.19 Million. a decrease over the revenue in the year 2023 that were of โ‚ฌ0.75 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ0.2 M-72.2%
2023 โ‚ฌ0.75 M-92.13%
2022 โ‚ฌ9.56 M510.49%
2021 โ‚ฌ1.56 M-73.99%
2020 โ‚ฌ6.02 M64.15%
2019 โ‚ฌ3.67 M-86.22%
2018 โ‚ฌ26.64 M-24.28%
2017 โ‚ฌ35.18 M4.65%
2016 โ‚ฌ33.62 M-9.38%
2015 โ‚ฌ37.1 M331.58%
2014 โ‚ฌ8.59 M-11.83%
2013 โ‚ฌ9.75 M213.2%
2012 โ‚ฌ3.11 M-58.72%
2011 โ‚ฌ7.54 M63.27%
2010 โ‚ฌ4.61 M-27.43%
2009 โ‚ฌ6.36 M324.25%
2008 โ‚ฌ1.5 M-54.43%
2007 โ‚ฌ3.29 M25.27%
2006 โ‚ฌ2.62 M-43.05%
2005 โ‚ฌ4.61 M436.43%
2004 โ‚ฌ0.86 M1245.12%
2003 โ‚ฌ0.06 M-64.72%
2002 โ‚ฌ0.18 M
2000 โ‚ฌ5.9 M-32.44%
1999 โ‚ฌ8.74 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ58.12 B 29,218,842.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ81.13 B 40,789,131.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.28 M 1,048.07%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ47.24 B 23,752,173.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ58.61 B 29,467,744.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ36.70 B 18,452,000.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ26.26 B 13,204,128.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.57 M 190.16%๐Ÿ‡บ๐Ÿ‡ธ USA